Showing 1 - 14 results of 14 for search 'Eva Domingo Domènech', query time: 0.04s
Refine Results
-
1
Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation by Eva Domingo-Domènech, Anna Sureda
Published 2020-05-01
Article -
2
-
3
-
4
PB2329: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL): MULTICENTRIC REVIEW OF CLINICAL FEATURES AND TREATMENT: ON BEHALF OF GELTAMO (GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTES DE MÉDU... by Maria Stefania Infante, Alejandro Martin Garcia-Sancho, Hugo Luzardo, Marta Gomez, Eva Domingo Domènech
Published 2023-08-01
Article -
5
Comparison of different automatic methods for the delineation of the total metabolic tumor volume in I–II stage Hodgkin Lymphoma by Queralt Martín-Saladich, Gabriel Reynés-Llompart, Aida Sabaté-Llobera, Azahara Palomar-Muñoz, Eva Domingo-Domènech, Montse Cortés-Romera
Published 2020-07-01
Article -
6
P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PH... by Swaminathan Iyer, Deepa Jagadeesh, Eva Domingo Domènech, Fabio Benedetti, Antonia Rodriguez Izquierdo, Kamal Bouabdallah, Umberto Vitolo, Tim Illidge, Jingmin Liu, Scott Knowles, Steven Horwitz
Published 2023-08-01
Article -
7
Liquid biopsy for disease monitoring after anti‐CD19 chimeric antigen receptor T cell in diffuse large B‐cell lymphoma by Clara Maluquer, Beatriz Bellosillo, Alberto Mussetti, Eva Domingo‐Domènech, Rocío Parody, Lierni Fernández‐Ibarrondo, Roser Velasco, Gabriel Moreno‐González, Gabriela Sanz, Montserrat Cortés, Anna Sureda
Published 2021-02-01
Article -
8
P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST-HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY by Won-Seog Kim, Jake Shortt, Pier Luigi Zinzani, Natalya Mikhaylova, Ana Marin-Niebla, Dejan Radeski, Vincent Ribrag, Eva Domingo Domènech, Ahmed Sawas, Karenza Alexis, Michael Emig, Linta Garcia, Andre Overesch, Kerstin Pietzko, Steven Horwitz
Published 2023-08-01
Article -
9
The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients by Valeria Castelli, Enric Sastre-Escolà, Pedro Puerta-Alcalde, Leyre Huete-Álava, Júlia Laporte-Amargós, Alba Bergas, Mariana Chumbita, Mar Marín, Eva Domingo-Domenech, Ana María Badia-Tejero, Paula Pons-Oltra, Carolina García-Vidal, Jordi Carratalà, Carlota Gudiol
Published 2023-12-01
Article -
10
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies by Lourdes Farre, Gabriela Sanz, Neus Ruiz-Xivillé, Manuel Castro de Moura, Juan Francisco Martin-Tejera, Samuel Gonçalves-Ribeiro, Maria Martinez-Iniesta, Monica Calaf, Jose Luis Mosquera, José Ignacio Martín-Subero, Isabel Granada, Manel Esteller, Eva Domingo-Domenech, Fina Climent, Alberto Villanueva, Anna Sureda
Published 2021-07-01
Article -
11
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Tri... by Andrea Gallamini, Marco Picardi, Kateryna Filonenko, Manuel Gotti, Javier Núñez Céspedes, Andrea Rossi, Eva Domingo-Domènech, Agnieszka Giza, Roberto Sorasio, Livio Trentin, Mariana Bastos Oteiro, Ewa Paszkiewicz-Kozik, Ramon García Sanz, Caterina Patti, Stephane Chauvie, Fabrizio Bergesio, Luca Guerra, Alessandro Rambaldi, Ana Sureda Balari, Jan Maciej Zaucha
Published 2022-10-01
Article -
12
The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting by Maria Condom, Alberto Mussetti, Clara Maluquer, Rocío Parody, Eva González‐Barca, Montserrat Arnan, Adaia Albasanz‐Puig, Helena Pomares, Maria Queralt Salas, Itziar Carro, Marta Peña, Victòria Clapes, Cristina Baca Cano, Ana Carla Oliveira Ramos, Gabriela Sanz‐Linares, Gabriel Moreno‐González, Santiago Mercadal, Concepcion Boqué, Carlota Gudiol, Eva Domingo‐Domènech, Anna Sureda
Published 2021-08-01
Article -
13
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment by Mariana Bastos Oreiro, Reyes Martín, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, Marta Liébana, Belén Navarro, Blanca Sánchez-González, Pilar Marí, Jaime Pérez de Oteiza, Antonio Gutiérrez, Leyre Bento, Eva Domingo Doménech, María Jesús Vidal, Raquel Del Campo, Elena Pérez Ceballos, María Infante, Alicia Roldán, Daniel García Belmonte, Miriam Santero, Anna Sureda, Ramón García Sanz, on behalf of the GELTAMO Group
Published 2021-05-01
Article -
14
T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma. Interim Results of the BRESELIBET Prospective Clin... by Anna Sureda-Balari, M. José Terol, Eva Domingo-Domènech, Ana Pilar González Rodriguez, Francisca Hernández Mohedo, Javier Núñez Céspedes, Fátima De La Cruz Vicente, Carmen Martínez Muñoz, M. Elena Amutio Díaz, Raul Córdoba, Antonia Rodríguez Izquierdo, Samuel Romero Domínguez, Javier Briones Meijide, Richard Greil, Miriam Moreno Velázquez, Araceli Rubio, Mariana Bastos Oteiro, Pilar Gómez, Irit Avivi, María Casanova, Raquel Del Campo García, Victor Noriega, José Javier Sánchez Blanco, Ramón. García Sanz
Published 2022-10-01
Article